“The developing outlook reflects our view of CNE’s upside potential for the rating given the definitive agreement recently signed by CNE and Partners, thereby formalizing Partners’ planned acquisition of CNE pending approvals by both Rhode Island and Massachusetts regulators,” said S&P credit analyst Jennifer Soule.
The developing outlook also indicates a potential downside, which is reflected by CNE’s weak financial performance, unhealthy balance sheet metrics and fluctuating patient volume trends.
More articles on healthcare finance:
$28k: The average price healthcare will cost a family of 4 in 2018
10 recent hospital, health system outlook and credit rating actions
MedData names acting president: 3 things to know
